PRA-178881 Chronic hepatitis B virus infections € 2.511,-

Many places available


Study of a new investigational compound that is being developed for the treatment of chronic hepatitis B virus infections

Requested participants

  • M/F, healthy, 18 - 55 years old
  • Non-smokers only

Duration and visits

  • 21 days stay

Learn more about this research?

Research details


  • You do not smoke.
  • Your Body Mass Index (BMI) is between 18 and 30 kg/m2. The BMI reflects the relation between your body weight in kilograms and your height in meters.
  • For females with a male partner: you are only allowed to participate in this study if you are using sufficient
    contraception (for this study, only a barrier method, such as a condom, combined with a non-hormonal
    intrauterine device is allowed) or if you have been postmenopausal for minimum of 12 months or if you
    have been sterilized.
  • To determine if you are eligible to participate in this study, you will undergo a medical screening.
Calculate BMI


You will receive a gross compensation of € 2.511,- for full participation in Group 1.

Travelling expenses will be reimbursed based on the distance traveled (€ 0,19 net per kilometer) with a minimum of € 12,- and a maximum of € 160,- (840 kilometers) per return, irrespective of the method of transportation.

Period of stay and research

The study consists of 1 period during which you will stay in our research facility in Groningen (UMCG site) for 21
days (20 nights).

Please note: You have to be available for the entire period to participate in this study. These are the currently planned dates; however, these may be subject to change. If the dates do change you will be notified as soon as possible.


Group 1

€ 2.511,-

21 days stay

  • 3 Jun 2018 up to and including 23 Jun 2018

short stay


Call me back

We bellen terug tijdens kantooruren binnen 3 werkdagen.

Bel mij terug
  • ?

  • ?